Sandbox:Balanitis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vishal Devarkonda, M.B.B.S[2]
Synonyms and keywords: balanoposthitis
Overview
Historical Perspective
Classification
Pathophysiology
Infectious
Non-infectious
Causes
Causes of Balanitis include the following:
- Candidal balanitis
- Anaerobic balanitis
- Aerobic balanitis
- Lichen sclerosus
- Lichen planus
- Zoon’s (plasma cell) balanitis
- Psoriasis and circinate balanitis
- Eczema (including irritant, allergic and seborrhoeic)
- Non-specific balanoposthitis
- Fixed drug eruptions
Premalignant conditions:
- Erythroplasia of Queyrat
- Bowen’s disease
- Bowenoid papulosis
Miscellaneous
Stevens-Johnson syndrome
Differentiating Candida Vulvovaginitis from other Diseases
Candida Vulvovaginitis must be differentiated from the following diseases which have a similar presentation:[1][2][3][4][5]
Disease | Findings |
---|---|
Trichomoniasis |
|
Atrophic vaginitis |
|
Desquamative inflammatory vaginitis |
|
Bacterial Vaginosis |
|
Epidemiology and Demographics
- Epidemiological studies on Candida vulvovaginitis are hard to perform, because of several factors:[6][7]
- Candida vulvovaginitis is not a reportable disease.
- The diagnosis of Candida vulvovaginitis is based on clinical presentation and positive laboratory findings. Relying on a positive culture alone would likely overestimate the prevalence of Candida vulvovaginitis.
- The use of over-the-counter (OTC) topical anti-fungals makes it difficult to conduct epidemiological studies.
- Candida is the second most common cause of vaginal infection in young women following Bacterial Vaginosis.[8]
Age
- Incidence of Candida vulvovaginitis is higher in pregnant women.[9][10]
- Women in reproductive age group are prone for Candida vulvovaginits and at least one episode is reported in 70 to 75% in this population group.[11]
- 40 to 50% of patients with a prior yeast infection have multiple episodes of yeast infection.[9]
- Among the adult population 5 to 8% women have more than four episodes of infection.[12]
- In 20% asymptomatic healthy adolescent women, candida species can be isolated from the vagina.[13]
Race
Candida vulvovaginitis is more prevalent among African American women than white American women.[12]
Risk Factors
Risk factors for Balanitis include:
- Uncircumcised penis
- Antibiotic use
- Corticosteroid use
- Immunocompromised
- Diabetes
- Not usually considered sexually transmitted
Screening
There are no screening procedures for Balanitis.
Natural History, Complications and Prognosis
Natural History
Prognosis
Complications
Diagnosis
History and Symptoms
Symptoms include:
- Redness of foreskin or penis
- Other rashes on the head of the penis
- Foul-smelling discharge
- Painful penis and foreskin
Physical Examination
Laboratory Findings
Treatment
Medical Therapy
Surgical Therapy
Prevention
Primary Prevention
Secondary Prevention
References
- ↑ Centers for Disease Control and Prevention. 2015 Sexually Transmitted Diseases Treatment Guidelines. Bacterial Vaginosis. http://www.cdc.gov/std/tg2015/bv.htm Accessed on October 13, 2016
- ↑ Bachmann GA, Nevadunsky NS (2000). "Diagnosis and treatment of atrophic vaginitis". Am Fam Physician. 61 (10): 3090–6. PMID 10839558.
- ↑ Krieger JN, Tam MR, Stevens CE, Nielsen IO, Hale J, Kiviat NB; et al. (1988). "Diagnosis of trichomoniasis. Comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens". JAMA. 259 (8): 1223–7. PMID 2448502.
- ↑ Sobel JD, Reichman O, Misra D, Yoo W (2011). "Prognosis and treatment of desquamative inflammatory vaginitis". Obstet Gynecol. 117 (4): 850–5. doi:10.1097/AOG.0b013e3182117c9e. PMID 21422855.
- ↑ Eckert LO, Hawes SE, Stevens CE, Koutsky LA, Eschenbach DA, Holmes KK (1998). "Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm". Obstet Gynecol. 92 (5): 757–65. PMID 9794664.
- ↑ Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, Reed BD, Summers PR (1998). "Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations". Am. J. Obstet. Gynecol. 178 (2): 203–11. PMID 9500475.
- ↑ Sobel JD (2007). "Vulvovaginal candidosis". Lancet. 369 (9577): 1961–71. doi:10.1016/S0140-6736(07)60917-9. PMID 17560449.
- ↑ Allsworth JE, Peipert JF (2007). "Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data". Obstet Gynecol. 109 (1): 114–20. doi:10.1097/01.AOG.0000247627.84791.91. PMID 17197596.
- ↑ 9.0 9.1 Hurley R, De Louvois J (1979). "Candida vaginitis". Postgrad Med J. 55 (647): 645–7. PMC 2425644. PMID 523355.
- ↑ García Heredia M, García SD, Copolillo EF, Cora Eliseth M, Barata AD, Vay CA; et al. (2006). "[Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents]". Rev Argent Microbiol. 38 (1): 9–12. PMID 16784126.
- ↑ Zuckerman, Andrea; Romano, Mary (2016). "Clinical Recommendation: Vulvovaginitis". Journal of Pediatric and AdolescentGynecology. 29 (6): 673–679. doi:10.1016/j.jpag.2016.08.002. ISSN 1083-3188.
- ↑ 12.0 12.1 Foxman B, Marsh JV, Gillespie B, Sobel JD (1998). "Frequency and response to vaginal symptoms among white and African American women: results of a random digit dialing survey". J Womens Health. 7 (9): 1167–74. PMID 9861594.
- ↑ Barousse, M M (2004). "Vaginal yeast colonisation, prevalence of vaginitis, and associated local immunity in adolescents". Sexually Transmitted Infections. 80 (1): 48–53. doi:10.1136/sti.2002.003855. ISSN 1368-4973.